Business Description
Infinium Pharmachem Ltd
ISIN : INE0MRE01011
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.06 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | 0.57 | |||||
Interest Coverage | 8.46 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 14.11 | |||||
Beneish M-Score | -0.55 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.4 | |||||
3-Year EBITDA Growth Rate | 54.7 | |||||
3-Year EPS without NRI Growth Rate | 60.8 | |||||
3-Year Book Growth Rate | 103 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.6 | |||||
9-Day RSI | 60.52 | |||||
14-Day RSI | 59.2 | |||||
6-1 Month Momentum % | 73.35 | |||||
12-1 Month Momentum % | 42.44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.73 | |||||
Quick Ratio | 2.32 | |||||
Cash Ratio | 0.68 | |||||
Days Inventory | 75.05 | |||||
Days Sales Outstanding | 57.89 | |||||
Days Payable | 27.6 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -2.11 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 23.99 | |||||
Operating Margin % | 11.77 | |||||
Net Margin % | 8.33 | |||||
FCF Margin % | -12.21 | |||||
ROE % | 25.07 | |||||
ROA % | 13.14 | |||||
ROIC % | 18.69 | |||||
3-Year ROIIC % | 19.37 | |||||
ROC (Joel Greenblatt) % | 34.09 | |||||
ROCE % | 30.88 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 40.15 | |||||
PE Ratio without NRI | 40.03 | |||||
PS Ratio | 3.34 | |||||
PB Ratio | 7.72 | |||||
Price-to-Tangible-Book | 7.92 | |||||
EV-to-EBIT | 27.19 | |||||
EV-to-EBITDA | 23.53 | |||||
EV-to-Revenue | 3.43 | |||||
EV-to-FCF | -27.19 | |||||
Price-to-Graham-Number | 3.8 | |||||
Price-to-Net-Current-Asset-Value | 12.15 | |||||
Earnings Yield (Greenblatt) % | 3.69 | |||||
FCF Yield % | -3.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Infinium Pharmachem Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 1,356.392 | ||
EPS (TTM) (₹) | 8.12 | ||
Beta | 0 | ||
Volatility % | 84.08 | ||
14-Day RSI | 59.2 | ||
14-Day ATR (₹) | 12.185025 | ||
20-Day SMA (₹) | 328.1 | ||
12-1 Month Momentum % | 42.44 | ||
52-Week Range (₹) | 178.05 - 392.5 | ||
Shares Outstanding (Mil) | 13.92 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Infinium Pharmachem Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Infinium Pharmachem Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Infinium Pharmachem Ltd Frequently Asked Questions
What is Infinium Pharmachem Ltd(NSE:INFINIUM)'s stock price today?
When is next earnings date of Infinium Pharmachem Ltd(NSE:INFINIUM)?
Does Infinium Pharmachem Ltd(NSE:INFINIUM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |